ENTECAVIR Side Effects

6867388-3 | Fracture, Limb Injury
on Jul 19, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 61 years of age, weighting 108.0 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: fracture (What is fracture?), limb injury. Entecavir dosage: Df=0.5(unit Not Specified). Patient was hospitalized.

6818853-6 | Blood Amylase Increased, Pancreatitis
Patient was taking Entecavir (View Usage). Patient had the following side effects: blood amylase increased, pancreatitis on Jul 01, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with hepatitis b (What is hepatitis b?), diabetes mellitus, cerebrovascular accident prophylaxis, hypertension, diarrhoea and. Entecavir dosage: Last Dosing: 12sep09. During the same period patient was treated with METFORMIN HCL (Reduced To 500 Bid) (View Metformin Hcl Review and Metformin Hcl Label ), LANTUS (1 Df=40 Untis) (View Lantus Review and Lantus Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), MICARDIS (View Micardis Review and Micardis Label ), LOMOTIL (View Lomotil Review and Lomotil Label ).

6803675-2 | Fracture, Limb Injury
Adverse event was reported on Jun 22, 2010 by a Female patient taking Entecavir (View Usage) (Dosage: Df=0.5(unit Not Specified)) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: TAIWAN, PROVINCE OF CHINA , 61 years of age, weighting 108.0 lb, After Entecavir was administered, patient had the following side effects: fracture (What is fracture?), limb injury. Patient was hospitalized.

6732665-3 | Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased
on May 05, 2009 Male patient from UNITED STATES , 70 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood bilirubin increased. Entecavir dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), SEPTRA (View Septra Review and Septra Label ).


6723487-8 | Hepatic Neoplasm Malignant
on May 10, 2010 Male patient from AUSTRALIA , 42 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient had the following side effects: hepatic neoplasm malignant. Entecavir dosage: .

6715266-2 | Malignant Melanoma
Patient was taking Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: malignant melanoma on May 05, 2010 from ROMANIA Additional patient health information: Female patient , 36 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: .

6689414-7 | Gastric Cancer, Gastric Ulcer
Adverse event was reported on Apr 16, 2010 by a Male patient taking Entecavir (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?), psoriatic arthropathy and. Location: GERMANY , 44 years of age, weighting 222.7 lb, Patient experienced the following unwanted or unexpected effects: gastric cancer, gastric ulcer. During the same period patient was treated with ETANERCEPT (View Etanercept Review and Etanercept Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), PREDNISOLONE (1dosageform=5-20mg) (View Prednisolone Review and Prednisolone Label ), METHOTREXATE (Sep06-sep07,restarted On Jan09) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ).

6656920-0 | Blood Amylase Increased, Pancreatitis
on Mar 25, 2010 Female patient from UNITED STATES , 61 years of age, was diagnosed with hepatitis b (What is hepatitis b?), diabetes mellitus, cerebrovascular accident prophylaxis, hypertension, diarrhoea and was treated with Entecavir (View Usage). Patient had the following side effects: blood amylase increased, pancreatitis. Entecavir dosage: Last Dosing: 12sep09. During the same period patient was treated with METFORMIN HYDROCHLORIDE (Reduced To 500 Bid) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LANTUS (1 Df=40 Untis) (View Lantus Review and Lantus Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), MICARDIS (View Micardis Review and Micardis Label ), LOMOTIL (View Lomotil Review and Lomotil Label ).

6637469-8 | Blood Amylase Increased, Pancreatitis
on Mar 11, 2010 Female patient from UNITED STATES , 61 years of age, was diagnosed with hepatitis b (What is hepatitis b?), diabetes mellitus, cerebrovascular accident prophylaxis, hypertension, diarrhoea and was treated with Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: blood amylase increased, pancreatitis. Entecavir dosage: Last Dosing: 12sep09. During the same period patient was treated with METFORMIN HYDROCHLORIDE (Reduced To 500 Bid) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LANTUS (1 Df=40 Untis) (View Lantus Review and Lantus Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), MICARDIS (View Micardis Review and Micardis Label ), LOMOTIL (View Lomotil Review and Lomotil Label ).

6628677-0 | Hepatic Neoplasm Malignant
Patient was taking Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant on Mar 01, 2010 from AUSTRALIA Additional patient health information: Male patient , 48 years of age, . Entecavir dosage: .

6618028-X | Hepatic Neoplasm
Adverse event was reported on Feb 25, 2010 by a Male patient taking Entecavir (View Usage) (Dosage: ) . Location: AUSTRALIA , 48 years of age, Patient had the following side effects: hepatic neoplasm.

6577957-6 | Lactic Acidosis
on Feb 08, 2010 Male patient from GERMANY , 36 years of age, weighting 158.7 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: lactic acidosis. Entecavir dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ).

6567638-7 | Blood Amylase Increased, Pancreatitis
on Jan 27, 2010 Female patient from UNITED STATES , 61 years of age, was diagnosed with hepatitis b (What is hepatitis b?), diabetes mellitus, cerebrovascular accident prophylaxis, hypertension, diarrhoea and was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: blood amylase increased, pancreatitis. Entecavir dosage: . During the same period patient was treated with METFORMIN HCL (Reduced To 500 Bid) (View Metformin Hcl Review and Metformin Hcl Label ), LANTUS (1 Df=40 Untis) (View Lantus Review and Lantus Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), MICARDIS (View Micardis Review and Micardis Label ), LOMOTIL (View Lomotil Review and Lomotil Label ).

6543565-6 | Bile Duct Stone, Blood Amylase Increased, Pancreatitis
Patient was taking Entecavir (View Usage). Patient had the following side effects: bile duct stone, blood amylase increased, pancreatitis on Jan 13, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with hepatitis b (What is hepatitis b?), diabetes mellitus, cerebrovascular accident prophylaxis, hypertension, diarrhoea and. Entecavir dosage: . During the same period patient was treated with METFORMIN (Reduced To 500 Bid) (View Metformin Review and Metformin Label ), LANTUS (1 Df=40 Untis) (View Lantus Review and Lantus Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), MICARDIS (View Micardis Review and Micardis Label ), LOMOTIL (View Lomotil Review and Lomotil Label ).

6538981-2 | Gastric Cancer, Gastric Ulcer
Adverse event was reported on Jan 12, 2010 by a Male patient taking Entecavir (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?), psoriatic arthropathy and. Location: GERMANY , 44 years of age, weighting 222.7 lb, After Entecavir was administered, patient had the following side effects: gastric cancer, gastric ulcer. During the same period patient was treated with ETANERCEPT (View Etanercept Review and Etanercept Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), PREDNISOLONE (1dosageform=5-20mg) (View Prednisolone Review and Prednisolone Label ), METHOTREXATE (Sep06-sep07,restarted On Jan09) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ).

6509491-3 | Blood Amylase Increased, Pancreatitis
on Dec 10, 2009 Female patient from UNITED STATES , 61 years of age, was diagnosed with hepatitis b (What is hepatitis b?), diabetes mellitus, cerebrovascular accident prophylaxis, hypertension, diarrhoea and was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: blood amylase increased, pancreatitis. Entecavir dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LANTUS (1 Df=40 Untis) (View Lantus Review and Lantus Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), MICARDIS (View Micardis Review and Micardis Label ), LOMOTIL (View Lomotil Review and Lomotil Label ).

6509488-3 | Blood Hiv Rna Decreased
on Dec 08, 2009 Male patient from UNITED STATES , 45 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient had the following side effects: blood hiv rna decreased (What is blood hiv rna decreased?). Entecavir dosage: .

6401458-9 | Lactic Acidosis
Patient was taking Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: lactic acidosis on Oct 12, 2009 from GERMANY Additional patient health information: Female patient , 60 years of age, weighting 220.5 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: Taken Every 2-3 Days Interrupted On 09jan09 Restarted On 15jan09 Stopped On 08feb09. During the same period patient was treated with SIROLIMUS (View Sirolimus Review and Sirolimus Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

6401457-7 | Acute Hepatic Failure, Dyspnoea, Fatigue, Lactic Acidosis, Motor Dysfunction
Adverse event was reported on Oct 12, 2009 by a Female patient taking Entecavir (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 80 years of age, Patient experienced the following unwanted or unexpected effects: acute hepatic failure, dyspnoea, fatigue, lactic acidosis, motor dysfunction. During the same period patient was treated with PANTOZOL (For Weeks) (View Pantozol Review and Pantozol Label ), METOPROLOL (For Weeks) (View Metoprolol Review and Metoprolol Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

6401456-5 | Lactic Acidosis
on Oct 12, 2009 Male patient from GERMANY , 36 years of age, weighting 158.7 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient had the following side effects: lactic acidosis. Entecavir dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ).

6368284-0 | Dyspnoea, Hyperkalaemia, Hyponatraemia, Oesophageal Varices Haemorrhage, Pneumonia
on Sep 14, 2009 Female patient from UNITED STATES , 79 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: dyspnoea, hyperkalaemia, hyponatraemia, oesophageal varices haemorrhage, pneumonia (What is pneumonia?). Entecavir dosage: . During the same period patient was treated with SPIRONOLACTONE TABLETS, USP (View Spironolactone Tablets, Usp Review and Spironolactone Tablets, Usp Label ), NADOLOL (View Nadolol Review and Nadolol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), BLEPHAMIDE /00319401/ (View Blephamide /00319401/ Review and Blephamide /00319401/ Label ), LASIX (View Lasix Review and Lasix Label ), UNIPHYL (View Uniphyl Review and Uniphyl Label ). Patient was hospitalized.

6341556-1 | Hepatitis
Patient was taking Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?) on Sep 03, 2009 from IRELAND Additional patient health information: Female patient , 70 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6337986-4 | Lactic Acidosis
Adverse event was reported on Sep 01, 2009 by a Female patient taking Entecavir (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 80 years of age, Patient had the following side effects: lactic acidosis. During the same period patient was treated with PANTOZOL (For Weeks) (View Pantozol Review and Pantozol Label ), METOPROLOL (For Weeks) (View Metoprolol Review and Metoprolol Label ).

6336196-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Aug 25, 2009 Male patient from POLAND , 41 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Entecavir dosage: Interrupted. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ).

6335241-X | Optic Neuritis
on Aug 27, 2009 Female patient from ARGENTINA , 47 years of age, was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: optic neuritis. Entecavir dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ).

6334938-5 | Lactic Acidosis
Patient was taking Entecavir (View Usage). Patient had the following side effects: lactic acidosis on Aug 11, 2009 from GERMANY Additional patient health information: Female patient , 61 years of age, weighting 231.5 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: Reduced To 0.5 Mg/day. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6334935-X | Lactic Acidosis
Adverse event was reported on Aug 11, 2009 by a Female patient taking Entecavir (View Usage) (Dosage: Taken Every 2-3 Days Interrupted On 09jan09 Restarted On 15jan09 Stopped On 08feb09) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 60 years of age, weighting 220.5 lb, After Entecavir was administered, patient had the following side effects: lactic acidosis. During the same period patient was treated with SIROLIMUS (View Sirolimus Review and Sirolimus Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

6334933-6 | Lactic Acidosis
on Aug 11, 2009 Male patient from GERMANY , 36 years of age, weighting 158.7 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis. Entecavir dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ).

6334932-4 | Lactic Acidosis
on Aug 11, 2009 Female patient from GERMANY , 80 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient had the following side effects: lactic acidosis. Entecavir dosage: . During the same period patient was treated with PANTOZOL (For Weeks) (View Pantozol Review and Pantozol Label ), METOPROLOL (For Weeks) (View Metoprolol Review and Metoprolol Label ).

6309605-4 | Optic Neuritis
Patient was taking Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: optic neuritis on Aug 11, 2009 from ARGENTINA Additional patient health information: Female patient , 47 years of age, . Entecavir dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ).

6299941-2 | Lactic Acidosis
Adverse event was reported on Aug 03, 2009 by a Female patient taking Entecavir (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 60 years of age, Patient experienced the following unwanted or unexpected effects: lactic acidosis.

6296009-6 | Hepatitis B Dna Increased
on Jul 20, 2009 Female patient from AUSTRALIA , 40 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient had the following side effects: hepatitis b dna increased. Entecavir dosage: Increased To 1mg On 08aug07.

6287924-8 | Lactic Acidosis
on Jul 24, 2009 Male patient from GERMANY , 36 years of age, weighting 158.7 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: lactic acidosis. Entecavir dosage: Interrupted On 18dec07.. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ).

6286783-7 | Lactic Acidosis
Patient was taking Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis on Jul 24, 2009 from GERMANY Additional patient health information: Female patient , 61 years of age, weighting 231.5 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: Reduced To 0.5 Mg/day. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ). Patient was hospitalized.

6286761-8 | Lactic Acidosis
Adverse event was reported on Jul 24, 2009 by a Female patient taking Entecavir (View Usage) (Dosage: Taken Every 2-3 Days Interrupted On 09jan09 Restarted On 15jan09 Stopped On 08feb09) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 60 years of age, weighting 220.5 lb, Patient had the following side effects: lactic acidosis. During the same period patient was treated with SIROLIMUS (View Sirolimus Review and Sirolimus Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

6282980-5 | Hepatitis
on Jul 16, 2009 Female patient from UNITED STATES , 70 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: hepatitis (What is hepatitis?). Entecavir dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6258877-3 | Lactic Acidosis
on Jul 02, 2009 Female patient from GERMANY , 80 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis. Entecavir dosage: . During the same period patient was treated with PANTOZOL (For Weeks) (View Pantozol Review and Pantozol Label ), METOPROLOL TARTRATE (For Weeks) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6255970-6 | Lactic Acidosis
Patient was taking Entecavir (View Usage). Patient had the following side effects: lactic acidosis on Jul 02, 2009 from GERMANY Additional patient health information: Female patient , 80 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: . During the same period patient was treated with PANTOZOL (For Weeks) (View Pantozol Review and Pantozol Label ), METOPROLOL SUCCINATE (For Weeks) (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

6255179-6 | Lactic Acidosis
Adverse event was reported on Jun 25, 2009 by a Female patient taking Entecavir (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 80 years of age, After Entecavir was administered, patient had the following side effects: lactic acidosis.

6254929-2 | Lactic Acidosis
on Jun 25, 2009 Female patient from GERMANY , 61 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis. Entecavir dosage: .

6254918-8 | Lactic Acidosis
on Jun 25, 2009 Female patient from GERMANY , 60 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient had the following side effects: lactic acidosis. Entecavir dosage: .

6254904-8 | Lactic Acidosis
Patient was taking Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: lactic acidosis on Jun 25, 2009 from GERMANY Additional patient health information: Female patient , 60 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: .

6254897-3 | Lactic Acidosis
Adverse event was reported on Jun 25, 2009 by a Female patient taking Entecavir (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 36 years of age, Patient experienced the following unwanted or unexpected effects: lactic acidosis.

6216052-2 | Pancreatitis
on Jun 03, 2009 Male patient from BELGIUM , 49 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient had the following side effects: pancreatitis. Entecavir dosage: . Patient was hospitalized.

6214152-4 | Breast Cancer
on Jun 02, 2009 Female patient from AUSTRALIA , 46 years of age, weighting 130.1 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: breast cancer (What is breast cancer?). Entecavir dosage: .

6199437-2 | Pancreatitis
Patient was taking Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis on May 14, 2009 from CHINA Additional patient health information: Male patient , 49 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: . Patient was hospitalized.

6140129-3 | Hepatic Neoplasm Malignant
Adverse event was reported on Mar 27, 2009 by a Male patient taking Entecavir (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: POLAND , 66 years of age, Patient had the following side effects: hepatic neoplasm malignant. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6140126-8 | Hepatic Neoplasm Malignant
on Mar 27, 2009 Male patient from POLAND , 66 years of age, was diagnosed with hepatitis b (What is hepatitis b?), hepatic failure and was treated with Entecavir (View Usage). After Entecavir was administered, patient had the following side effects: hepatic neoplasm malignant. Entecavir dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6134549-0 | Coma
on Mar 24, 2009 Female patient from POLAND , 50 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Entecavir (View Usage). Patient experienced the following unwanted or unexpected effects: coma. Entecavir dosage: . During the same period patient was treated with ZEFIX (View Zefix Review and Zefix Label ). Patient was hospitalized.

6134508-8 | Diplopia, Listeria Encephalitis
Patient was taking Entecavir (View Usage). Patient had the following side effects: diplopia, listeria encephalitis on Mar 23, 2009 from BRAZIL Additional patient health information: Male patient , 21 years of age, weighting 132.3 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Entecavir dosage: Interrupted 12-may-2005.. Patient was hospitalized.